Table 1.

Sample characteristics (n=1,396)

	No.	%*
Race
White	1,126	80.66
African American	170	12.18
Hispanic	62	4.44
Asian	38	2.72
Age (years)
≤54	185	13.25
55-64	385	27.58
65-74	494	35.39
≥75	332	23.78
Gender
Male	722	51.72
Female	674	48.28
Income
<$20,000	399	30.83
≥$20,000 to <$40,000	393	30.37
≥$40,000 to <$60,000	231	17.85
≥$60,000	271	20.94
Education
Less than high school	235	16.91
High school graduate/GED	465	33.45
Some college/ vocational school	408	29.35
≥College degree	282	20.29
Covered by insurance
No	15	1.08
Yes	1,379	98.92
Comorbid conditions†
No	595	42.65
Yes	800	57.35
Number of conditions
Mean(SD)	0.87	(0.97)
(range)		(0-5)
Depression/emotional problems
No	1050	75.54
Yes	340	24.46
Cancer type
Non-small cell	1224	87.68
Small cell	108	7.74
Stage at diagnosis
Stage I	563	41.98
Stage II	156	11.63
Stage III	382	28.49
Stage IV	240	17.90
Time from diagnosis to initial survey (months)
Mean(SD)	4.80	(1.72)
(Range)		(2-12)
Time from diagnosis to follow-up (months)
Mean(SD)	13.70	(3.63)
(Range)		(9.13-41.57)
Treatment received by follow-up
Surgery only	459	37.09
Surgery followed by chemotherapy or	159	11.39
chemotherapy only
Surgery, chemotherapy and radiation	386	27.65
Chemotherapy and radiation, no surgery	307	21.99
Other†	85	6.09
Initial EQ-5D score
Mean(SD)	0.79	(0.16)
(Range)		(0.07-1.00)
Follow-up EQ-5D score
Mean(SD)	0.80	(0.17)
(Range)		(0.05-1.00)

^*Percentages may not total 100% due to missing values. Missing was <10%;

^†Heart attack, heart failure, stroke, diabetes, pulmonary function problems, kidney disease, diabetes;

^‡Radiation only or none